These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12469280)

  • 21. [A neuroprotective effect of the herbal drug neurofit in alcoholic intoxication].
    Dashinamzhilov ZhB; Lonshakova KS; Ubasheev IO; Nikolaev SM; Gulevich AA
    Patol Fiziol Eksp Ter; 2007; (4):27-9. PubMed ID: 18154085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
    Huber W; Willmes K; Poeck K; Van Vleymen B; Deberdt W
    Arch Phys Med Rehabil; 1997 Mar; 78(3):245-50. PubMed ID: 9084344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phenotropil in the treatment of vascular encephalopathy].
    Gustov AA; Smirnov AA; Korshunova IuA; Andrianova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):52-3. PubMed ID: 16608112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinicoimmunological effects of piracetam and aevit in the course of duodenal ulcer patients' therapy].
    Balobanov VI; Vakhrushev SP; Velikosel'skaia LM
    Klin Med (Mosk); 1996; 74(7):56-7. PubMed ID: 8992120
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia].
    Tiurenkov IN; Bagmetov MN; Epishina VV
    Eksp Klin Farmakol; 2007; 70(2):24-9. PubMed ID: 17523446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Piracetam treatment in ischemic stroke].
    Tomczykiewicz K; Domzał T
    Neurol Neurochir Pol; 1997; 31(6):1101-9. PubMed ID: 9591298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
    Onishchenko LS; Gaikova ON; Yanishevskii SN
    Neurosci Behav Physiol; 2008 Jan; 38(1):49-54. PubMed ID: 18097760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piracetam improves children's memory after general anaesthesia.
    Fesenko UA
    Anestezjol Intens Ter; 2009; 41(1):16-21. PubMed ID: 19517672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piracetam therapy for Down syndrome: a rush to judgment?
    Black SL
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176; author reply 1177-8. PubMed ID: 11576019
    [No Abstract]   [Full Text] [Related]  

  • 31. Piracetam: a novel therapy for autism?
    Paczynski M
    J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
    [No Abstract]   [Full Text] [Related]  

  • 32. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
    Bekuzarova MR; Burd GS; Kolesnikova TI; Iasamanova AN; Kabanov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):35-8. PubMed ID: 11517473
    [No Abstract]   [Full Text] [Related]  

  • 33. Piracetam study: poorly designed and misinterpreted.
    Croom J
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176-8. PubMed ID: 11576020
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Khani YA; Andermann F; Andermann E
    Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of mild cognitive disorders].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):121-5. PubMed ID: 24596976
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment and long-term follow-up of post-anoxic myoclonus].
    Janszky J; Holló A; Halász P
    Orv Hetil; 2001 Sep; 142(38):2091-3. PubMed ID: 11697066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinpocetine. Monograph.
    Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
    Gościński I; Moskała M; Cichoński J; Polak J; Krupa M; Sliwonik S; Sondej T
    Przegl Lek; 1999; 56(2):119-20. PubMed ID: 10375942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine].
    Kozlovskaia MM; Inozemtsev AN; Nikitin SV; Gochmuradov AG; Iakushev RA; Chabak-Gorbach R
    Biull Eksp Biol Med; 1995 Mar; 119(3):299-301. PubMed ID: 7795202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.